Abstract
Background: Head and Neck Surgery constantly has to oppose non-invasive organ preservation methods and therefore should be evaluated especially with regard to clinical and functional outcome. We will discuss the role of pharyngotomy in the treatment of HNSCC.
Methods: Seventy-three patients with carcinoma of the oral cavity, oro-/hypopharynx and supraglottis underwent lateral/median pharyngotomy. Functional and oncological parameters were retrospectively assessed and set into clinical context.
Results: The 5-year recurrence-free-interval (RFI) was significantly higher with surgery and adjuvant radio(chemo)therapy (80%; mean RFI: 92 months) when compared to conservative treatment (68%; mean RFI: 68 months). The 5-year overall-survival (OS) after surgery and conservative treatment was 71% and 54%, respectively. Compared to other surgical techniques (mean RFI: 82 months), pharyngotomy demonstrated a significant higher 5-year RFI (mean RFI: 89 months).
Conclusions: Pharyngotomy achieves good exposure and clear resection margins that result in a notably good oncological outcome with a minimum of functional loss. In particular, among UICC IV oropharyngeal HNSCC, pharyngotomy is superior in OS and RFI to conservative methods.
Chinese abstract
背景:头颈外科手术不断反对保守性保器官方法, 因此特别应该评估其临床和功能结果。我们将讨论咽部切开术在HNSCC治疗中的作用。
方法:73例口腔癌、口咽癌和咽上腺癌患者接受了侧/中位切开术。回顾性评估功能和肿瘤学参数, 并将其置于临床环境中。
结果:与保守治疗(68%;平均RFI:68个月)相比, 手术和辅助放疗(化疗)治疗(80%;平均RFI:92个月)的5年无复发期(RFI)高很多。手术后5年总生存期(OS)和保守治疗分别为71%和54%。与其它手术(平均RFI:82个月)相比, 咽切除术显示出高得多的5年RFI(平均RFI:89个月)。
结论:咽部切开术取得良好的暴露和清晰的切除缘, 导致明显良好的肿瘤学结果, 功能损失最小。特别是在UICC IV口咽HNSCC中, 咽部切除术在OS和RFI方面优于保守疗法。
Disclosure statement
No potential conflict of interest was reported by the authors.